Comparison of Atovaquone and Azithromycin with Trimethoprim-Sulfamethoxazole for the Prevention of Serious Bacterial Infections in Children with HIV Infection
Walter T. Hughes(St. Jude Children's Research Hospital), L. J. Wei(Harvard University), Sharon Huang(FuelCell Energy (United States)), Mónica Flores(San Juan City Hospital), Wayne M. Dankner(University of California San Diego), Ram Yogev(Northwestern University), Mark W. Kline(Tulane University), Mary E. Paul(Texas Children's Hospital)
Cited by 38
Related Papers
On the C‐statistics for evaluating overall adequacy of risk prediction procedures with censored survival data
|Statistics in Medicine|2011|1.5k
Lymphocyte subsets in healthy children from birth through 18 years of age
|Journal of Allergy and Clinical Immunology|2003|828
Moving Beyond the Hazard Ratio in Quantifying the Between-Group Difference in Survival Analysis
|Journal of Clinical Oncology|2014|777
Declines in Mortality Rates and Changes in Causes of Death in HIV-1-Infected Children During the HAART Era
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2009|281
Combination Therapy with Efavirenz, Nelfinavir, and Nucleoside Reverse-Transcriptase Inhibitors in Children Infected with Human Immunodeficiency Virus Type 1
|New England Journal of Medicine|1999|211